Lipase inhibitors to prevent rancidity in expressed human milk during storage
US-2020323225-A1 · Oct 15, 2020 · US
US12239142B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12239142-B2 |
| Application number | US-202418442060-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 14, 2024 |
| Priority date | Feb 15, 2023 |
| Publication date | Mar 4, 2025 |
| Grant date | Mar 4, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein, are compositions and methods for preserving human milk, preventing rancidity of human milk, extending shelf life of human milk, and maintaining the nutritional properties of human milk. Specifically, the present disclosure provides, among other things, devices for storing preserved human milk and methods and compositions for preserving the same.
Opening claim text (preview).
What is claimed is: 1. A composition for preserving human milk comprising: (a) pectin, wherein the pectin is: (i) between about 0.034 mg to about 9 mg; or (ii) between about 5 mg to about 1333 mg; or (iii) between about 34 mg to about 9000 mg; (b) vitamin C, wherein the vitamin C is: (i) between about 0.676 μg to about 101 μg; or (ii) between about 0.1 mg to about 15 mg; or iii) between about 0.676 mg to about 101 mg; and (c) vitamin E, wherein the vitamin E is: (i) between about 0.0122 μg to about 1.8 μg and the vitamin E is synthetic; or (ii) between about 1.8 μg to about 270 μg and the vitamin E is synthetic; or (iii) between about 0.01 mg to about 1.8 mg and the vitamin E is synthetic; or (iv) between about 0.01 μg to about 2.68 μg and the vitamin E is natural; or (v) between about 2.68 μg to about 402 μg and the vitamin E is natural; or (vi) between about 0.01 mg to about 2.68 mg and the vitamin E is natural. 2. The composition of claim 1 , further comprising lecithin. 3. The composition of claim 1 , further comprising one or more of a disintegrant, an absorbent, a colorant, a flavorant, a sweetener, or a dispersing agent. 4. The composition of claim 1 , further comprising a binder. 5. The composition of claim 1 , wherein the composition is formulated as one of a concentrated liquid, a tablet, a powder, or a single use sachet. 6. The composition of claim 1 , wherein the composition decreases lipase activity and maintains antioxidation capacity of the human milk. 7. The composition of claim 1 , wherein preserving the human milk comprises one or more of preventing rancidity of the human milk, extending shelf life of the human milk, and maintaining nutritional properties of the human milk upon storage. 8. The composition of claim 1 , wherein the pectin is a low methoxyl pectin or a high methoxyl pectin.
Colostrum; Human milk · CPC title
containing vitamins or antibiotics · CPC title
containing additives (fermented milk preparations containing additives A23C9/13) · CPC title
Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof · CPC title
by addition of preservatives (addition of microorganisms or enzymes A23C9/12; addition of other substances A23C9/152) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.